Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 7, 2016; 22(21): 5060-5067
Published online Jun 7, 2016. doi: 10.3748/wjg.v22.i21.5060
Published online Jun 7, 2016. doi: 10.3748/wjg.v22.i21.5060
Figure 1 SDS-PAGE analysis of purified recombinant proteins.
A: KatA; B: AhpC. 1: Marker; 2: Unpurified protein; 3: Purified protein. KatA: Catalase; AhpC: Alkyl hydroperoxide reductase.
Figure 2 Receiver operating characteristic curve for serum catalase antibody.
A: All subjects; B: H. pylori-positive subjects; C: H. pylori-negative subjects. H. pylori: Helicobacter pylori.
Figure 3 Receiver operating characteristic curve for serum alkyl hydroperoxide reductase antibody.
A: All subjects; B: H. pylori-positive subjects; C: H. pylori-negative subjects. H. pylori: Helicobacter pylori.
Figure 4 Receiver operating characteristic curve for combined analysis in all subjects.
A: KatA + FlaA; B: KatA + FlaA + AhpC. KatA: Catalase; AhpC: Alkyl hydroperoxide reductase; FlaA: Flagella protein A.
- Citation: Zhang B, Li HL, Fan Q, Guo F, Ren XY, Zhou HB, Zhu JW, Zhao YS, Tian WJ. Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer. World J Gastroenterol 2016; 22(21): 5060-5067
- URL: https://www.wjgnet.com/1007-9327/full/v22/i21/5060.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i21.5060